Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: Effect of an external standard on kit comparisons

Journal of Clinical Microbiology

Volumn 36, Issue 1, 1998, Pages 311-314

  Brambilla, Donald ^a   Leung, Sheila ^a   Lew, Judy ^b   Todd, John ^c   Herman, Steven ^d   Cronin, Mike ^e   Shapiro, David E ^f   Bremer, James ^g   Hanson, Celine ^h   Hillyer, George V ⁱ   Mcsherry, George D ^j   Sperling, Rhoda S ^k   Coombs, Robert W ^l   Reichelderfer, Patricia S ^b  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d HOFFMANN LA ROCHE INC   (United States)

^e Organon Teknika Corporation   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^j RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^k MOUNT SINAI MEDICAL CENTER   (United States)

^l UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; VIRUS CHARACTERIZATION; VIRUS DETECTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0031974575     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.1.311-314.1998     Document Type: Article

References (20)

1. BHIVA Guidelines Co-ordinating Committee. 1997. British HIV association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 349:1086-1092.
2. Carpenter, C. C. J., M. A. Fischl, S. M. Hammer, M. S. Hirsch, D. M. Jacobsen, D. A. Katzenstein, J. S. G. Montaner, D. D. Richman, M. S. Saag, R. T. Schooley, M. A. Thompson, S. Vella, P. G. Yeni, and P. A. Volberding for the International AIDS Society - USA. 1996. Antiretroviral therapy for HIV-1 infection in 1996. JAMA 276:146-154.
3. Connor, E. M., R. S. Sperling, R. Gelber, P. Kiselev, G. Scott, M. J. O'Sullivan, R. VanDyke, M. Bey, W. Shearer, R. L. Jacobson, E. Jimenez, E. O'Neill, B. Bazin, J. Delfraissy, M. Culnane, R. Coombs, M. Elkins, J. Moye, P. Stratton, and J. Balsley for The Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N. Engl. J. Med. 331:1173-1180.
4. Coombs, R. W. 1994. HIV-1 burden as a marker of disease progression and clinical response to therapy in AIDS. Clin. Lab. Med. 14:301-311.
5. 6/1. AIDS 11:53-57.
6. Holodniy, M., L. Mole, M. Winters, and T. C. Merigan. 1994. Diurnal and short-term stability of HIV virus load as measured by gene amplification. J. Acquired Immune Defic. Syndr. 7:363-368.
7. Kern, D., M. Collins, T. Fultz, J. Detmer, S. Hamren, J. J. Peterkin, P. Sheridan, M. Urdea, R. White, T. Yeghaizarian, and J. Todd. 1996. An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34:3196-3202.
8. Lin, H. J., L. E. Myers, B. Yen-Lieberman, F. B. Hollinger, D. Henrard, C. J. Hooper, R. Kokka, S. Kwok, S. Rasheed, M. Vahey, M. A. Winters, L. J. McQuay, P. L. Nara, P. Reichelderfer, R. W. Coombs, and J. B. Jackson. 1994. Multicenter evaluation of methods for the quantitation of plasma HIV-1 RNA. J. Infect. Dis. 170:553-562.
9. Merigan, T. 1995. Individualization of therapy using viral markers. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 10(Suppl. 1):S41-S46.
10. Mulder, J., N. McKinney, C. Christopherson, J. Sninsky, L. Greenfield, and S. Kwok. 1994. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J. Clin. Microbiol. 32:292-300.
11. Paxton, W. B., R. W. Coombs, M. J. McElrath, M. C. Keefer, J. Hughes, F. Sinangil, D. Chernoff, L. Demeter, B. Williams, and L. Corey for The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. 1997. Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-infected subjects with >400 CD4 lymphocytes: implications for applying measurements to individual patients. J. Infect. Dis. 175:247-254.
12. Revets, H., D. Marissens, S. De Wit, P. Lacor, N. Clumeck, S. Lauwers, and G. Zissis. 1996. Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV Monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34:1058-1064.
13. Saag, M. S., M. Holodniy, D. R. Kuritzkes, W. A. O'Brien, R. Coombs, M. E. Poscher, D. M. Jacobson, G. M. Shaw, D. D. Richman, and P. A. Volberding. HIV viral load markers in clinical practice. Nat. Med. 2:625-629.
14. Schuurman, R., D. Descamps, G. J. Weverling, S. Kaye, J. Tijnagel, I. Williams, R. van Leeuwen, R. Tedder, C. A. B. Boucher, F. Brun-Vezinet, and C. Loveday. 1996. Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34:3016-3022.
15. Sheon, A. R., H. E. Fox, K. C. Rich, P. Stratton, C. Diaz, R. Tuomala, H. Mendez, J. Carrington, and G. Alexander. 1996. The Women and Infants Transmission Study (WITS) of maternal-infant HIV transmission: study design, methods, and baseline data. J. Women's Health 5:69-78.
16. Sperling, R. S., D. E. Shapiro, R. W. Coombs, J. A. Todd, S. A. Herman, G. D. McSherry, M. J. O'Sullivan, K. B. Van Dyke, E. Jimenez, C. Rouzioux, P. M. Flynn, and J. L. Sullivan for The Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. 1996. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N. Engl. J. Med. 335:1621-1629.
17. Vandamme, A.-M., J.-C. Schmit, S. van Dooren, K. van Laethem, E. Gobbers, W. Kok, P. Goubau, M. Witvrouw, W. Peetermans, E. de Clercq, and J. Desmyter. 1996. Quantification of HIV-1 RNA in plasma: comparable results with NASBA HIV-1 RNA QT and the Amplicor HIV Monitor test. J. Acquired Immune Defic. Syndr. 13:127-139.
18. van Gemen, B., T. Kievits, R. Schukkink, D. van Strijp, L. T. Malek, R. Sooknanan, H. G. Huisman, and P. Lens. 1993. Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection. J. Virol. Methods 43:177-188.
19. Volberding, P. 1996. HIV quantification: clinical applications. Lancet 347: 71-73.
20. Yen-Lieberman, B., D. Brambilla, B. Jackson, J. Bremer, R. Coombs, M. Cronin, S. Herman, D. Katzenstein, S. Leung, H. J. Lin, P. Palumbo, S. Rasheed, J. Todd, M. Vahey, and P. Reichelderfer. 1996. Evaluation of a quality assurance program for quantification of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J. Clin. Microbiol. 34:2695-2701.